Presentation EuroPCR 2019 3-year clinical outcome following treatment with thin, very thin or ultrathin strut drug-eluting stents in small coronary vessels in BIO-RESORT Presenter: Clemens von Birgelen May 21, 2019
Presentation JIM 2019 Unmet Clinical Needs With Current Drug-Eluting Stents Presenter: Davide Capodanno February 14, 2019
Presentation JIM 2018 Overview of New Generation Drug-Eluting Stents Presenter: Gregg W. Stone February 22, 2018
Presentation Beyond Restenosis: Patients’ Preference for Drug-Eluting or Bare-Metal Stents February 13, 2017
Presentation TCT 2016 TRANSFORM-OCT: A Prospective, Randomized Trial Using OCT Imaging to Evaluate Strut Coverage at Three Months and Neoatherosclerosis at Eighteen Months in Bioresorbable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents Presenter: Gary S. Mintz, Robert-Jan van Geuns, Giulio Guagliumi November 02, 2016
Presentation TCT 2016 BIO-RESORT (TWENTE III): A Prospective, Randomized Three-Arm Trial Comparing Two Different Biodegradable Polymer-Based Drug-Eluting Stents and a Durable Polymer-Based Drug-Eluting Stent in an All-Comers Population of Patients With Coronary Artery Disease Presenter: Gregg W. Stone, Wayne B. Batchelor, Clemens von Birgelen October 30, 2016
Presentation ESC 2016 Drug-Eluting vs Bare Metal Stents in Saphenous Vein Grafts: The Prospective Randomized BASKET-SAVAGE Trial Presenter: Raban V. Jeger August 31, 2016
Presentation CCVVC 2016 Use of Drug Eluting Stents in the SFA: What are the Current Data, Real World Applications, Upcoming Trials Presenter: Tyrone Collins June 15, 2016
Presentation EuroPCR 2016 Sealing Moderate Coronary Saphenous Vein Graft Lesions with Drug-Eluting Stents as a New Approach to Reducing Cardiac Events The VELETI II Randomized Trial Presenter: Josep Rod?s-Cabau May 19, 2016
Presentation Fellows 2016 Drug-Eluting Stents: Past, Present, and Future Presenter: Gregg Stone April 15, 2016
Presentation JIM 2016 Excimer laser facilitated coronary angioplasty of a heavy calcified lesion treated with drug eluting stents Presenter: Antonio Mangieri February 12, 2016
Presentation CICT 2015 Drug Eluting Femoral Stents Where does it fit in my practice? Presenter: Yazan Khatib July 31, 2015
Presentation CCVVC 2015 Endovascular Management of SFA Instent Restenosis: Role of Atherectomy Drug-Eluting Stents Presenter: Craig M. Walker June 18, 2015
Presentation CCVVC 2015 Drug Eluting Stents in the treatment of SFA disease: Data and Current Trends Presenter: Suhail Dohad June 18, 2015
Presentation Fellows 2015 Drug-Eluting Stents: Past, Present, and Future Presenter: Manish A. Parikh, Roxana Mehran, Gregg W. Stone May 15, 2015
Presentation AHA 2014 Long-term Outcome of Biodegradable Compared to Durable Polymer Drug-Eluting Stents and Bare Metal Stents – Main Results of a Prospective Randomized Trial Presenter: C.Kaiser November 16, 2014
Presentation TCT 2014 RIBS IV: A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with Coronary In-Stent Restenosis of Drug-Eluting Stents Presenter: Gregg W. Stone, Pieter C. Smits, Fernando Alfonso September 14, 2014
Presentation TCT 2014 Bare Metal and Drug-Eluting Stents: Devices, Indications, and Outcomes Presenter: Emmanouil S. Brilakis, J. Dawn Abbott September 13, 2014
Presentation ESC 2014 SCAAR: Lower late and very late stent thrombosis rates with new generation drug eluting stents compared to bare metal stents Presenter: Christoph Varenhorst August 30, 2014
Presentation Fellows 2014 Drug-Eluting Stents: Past, Present, and Future Presenter: Gregg Stone April 12, 2014